70 related articles for article (PubMed ID: 23773684)
1. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
Shariatirad S; Maarefvand M; Ekhtiari H
Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
[No Abstract] [Full Text] [Related]
2. The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.
Walcher S; Koc J; Reichel V; Schlote F; Verthein U; Reimer J
BMC Pharmacol Toxicol; 2016 Apr; 17():15. PubMed ID: 27052201
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy in the treatment of addiction: methadone.
Kreek MJ; Borg L; Ducat E; Ray B
J Addict Dis; 2010 Apr; 29(2):200-16. PubMed ID: 20407977
[TBL] [Abstract][Full Text] [Related]
4. Case Presentations from the Addiction Academy.
Laes JR; Wiegand T
J Med Toxicol; 2016 Mar; 12(1):82-94. PubMed ID: 26586253
[TBL] [Abstract][Full Text] [Related]
5. No evidence of subgroups found in amphetamine consumers in Iran.
Bananej A; Völkl-Kernstock S; Lesch O; Walter H; Skala K
Neuropsychiatr; 2018 Jun; 32(2):69-74. PubMed ID: 29516360
[TBL] [Abstract][Full Text] [Related]
6. Predictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application.
Moeeni M; Razaghi EM; Ponnet K; Torabi F; Shafiee SA; Pashaei T
BMC Psychiatry; 2016 Jul; 16():265. PubMed ID: 27455958
[TBL] [Abstract][Full Text] [Related]
7. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
[TBL] [Abstract][Full Text] [Related]
8. The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs.
Mackay L; Bach P; Milloy MJ; Cui Z; Kerr T; Hayashi K
Drug Alcohol Depend; 2021 Aug; 225():108844. PubMed ID: 34182377
[TBL] [Abstract][Full Text] [Related]
9. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Ahmadi J; Razeghian Jahromi L
Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of substance and opium use among adult residents of Tehran; a comprehensive report from Tehran cohort study (TeCS).
Masoudkabir F; Shafiee A; Heidari A; Mohammadi NSH; Tavakoli K; Jalali A; Nayebirad S; Alaeddini F; Saadat S; Vasheghani-Farahani A; Sadeghian S; Arita VA; Boroumand M; Karimi A
BMC Psychiatry; 2024 Feb; 24(1):132. PubMed ID: 38365633
[TBL] [Abstract][Full Text] [Related]
11. Retention rate in methadone maintenance treatment and factors associated among referred patients from the compulsory residential centers compared to voluntary patients.
Radfar N; Radfar SR; Mohammadi F; Azimi A; Amirkafi A; Tehrani-Banihashemi A
Front Psychiatry; 2023; 14():1139307. PubMed ID: 37304442
[TBL] [Abstract][Full Text] [Related]
12. An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.
Giang LM; Trang NT; Diep NB; Thuy DTD; Thuy DT; Hoe HD; Van HTH; Truc TT; Nguyen HH; Lai NL; Linh PTD; Vi VTT; Reback CJ; Leibowitz A; Li L; Lin C; Li M; Do Van Dung ; Shoptaw S
Trials; 2022 Apr; 23(1):342. PubMed ID: 35461300
[TBL] [Abstract][Full Text] [Related]
13. Patterns of and Rationale for the Co-use of Methamphetamine and Opioids: Findings From Qualitative Interviews in New Mexico and Nevada.
Rhed BD; Harding RW; Marks C; Wagner KT; Fiuty P; Page K; Wagner KD
Front Psychiatry; 2022; 13():824940. PubMed ID: 35418887
[TBL] [Abstract][Full Text] [Related]
14. Trends in Poly Drug Use-associated Deaths based on Confirmed Analytical Toxicology Results in Tehran, Iran, in 2011-2016.
Akhgari M; Sardari-Iravani F; Ghadipasha M
Addict Health; 2021 Jan; 13(1):18-28. PubMed ID: 33995956
[TBL] [Abstract][Full Text] [Related]
15. Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study.
Tajbakhsh A; Alimardani M; Asghari M; Abedini S; Saghafi Khadem S; Nesaei Bajestani A; Alipoor F; Alidoust M; Savardashtaki A; Hashemian P; Pasdar A
BMC Med Genomics; 2021 Jan; 14(1):27. PubMed ID: 33499851
[TBL] [Abstract][Full Text] [Related]
16. Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors.
Lopez AM; Dhatt Z; Howe M; Al-Nassir M; Billing A; Artigiani E; Wish ED
Int J Drug Policy; 2021 May; 91():103098. PubMed ID: 33476863
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.
Aryan N; Banafshe HR; Farnia V; Shakeri J; Alikhani M; Rahimi H; Sehat M; Mamsharifi P; Ghaderi A; Omidi A
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):72. PubMed ID: 32977820
[TBL] [Abstract][Full Text] [Related]
18. Withdrawing attempt and its related factors among Iranian substance users: a case-control study.
Shahraki G; Sedaghat Z; Fararouei M
Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):45. PubMed ID: 30522516
[TBL] [Abstract][Full Text] [Related]
19. Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran.
Esmaeili A; Shokoohi M; Danesh A; Sharifi H; Karamouzian M; Haghdoost A; Shahesmaeili A; Akbarpour S; Morris MD; Mirzazadeh A
AIDS Behav; 2019 Jun; 23(6):1594-1603. PubMed ID: 30460664
[TBL] [Abstract][Full Text] [Related]
20. Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming, China.
Shen L; Assanangkornchai S; Liu W; Cai L; Li F; Tang S; Shen J; McNeil EB; Chongsuvivatwong V
PLoS One; 2018; 13(7):e0200105. PubMed ID: 29969481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
